Cue Biopharma Inc To Host Business Update Call Transcript
Greetings, and welcome to the Cue Biopharma Investor Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Daniel Passeri, CEO. Thank you, Daniel. You may begin.
All right. Thank you, and good afternoon, everyone. As a reminder, this presentation and discussion is being recorded and will be available on our website for the following 30 days. Those listening in may advance slides directly, and we'll notify you which slide we're on and discussing.
Joining me on today's call is Dr. Anish Suri, our President and Chief Scientific Officer; and Dr. Matteo Levisetti, our Chief Medical Officer. As shown here on Slide #2, this presentation and overview may contain some forward-looking statements, and any forward-looking statements made during the call represents the company's views only as of today, June 14, 2023.
After Matteo, I'll return for a brief summary, prior to opening the call up to questions. So first,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |